In an extraordinary roundtable attended by leaders in the field of cell and gene therapy (CGT), a renewed call to action was launched urging the U.S. Food and Drug Administration (FDA) to place their trust in American solutions to advance the field. Attendees of this roundtable included molecular geneticists, immunotherapists, physicians, nonprofit directors, and patient […]
